Holy Cross Health fka Holy Cross Hospital is located in Fort Lauderdale, Florida. The hospital is a non-profit, 557-bed Catholic hospital which operates in the spirit of the Sisters of Mercy. It is a member of Trinity Health.

There are 557 beds in Holy Cross Hospital.

During the past decade, Holy Cross Hospital conducted 168 clinical trials. In the 10-year time frame, 168 clinical trials started and 92 clinical trials were completed, i.e. on average, 54.8% percent of trials that started reached the finish line to date. In the past 5 years, 79 clinical trials started and 52 clinical trials were completed. i.e. 65.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Holy Cross Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 81 trials, followed by "Alliance for Clinical Trials in Oncology" with 20 trials sponsored, "SWOG Cancer Research Network" with 17 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 12 trials sponsored and "EMD Serono Research & Development Institute, Inc." with 12 trials sponsored. Other sponsors include 125 different institutions and companies that sponsored additional 86 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Holy Cross Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 65 trials as a collaborator, "NRG Oncology" with 10 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 7 trials as a collaborator and "Genentech, Inc." with 6 trials as a collaborator. Other collaborators include 102 different institutions and companies that were collaborators in the rest 82 trials.

According to Clinical.Site data, the most researched conditions in "Holy Cross Hospital" are "Breast Cancer" (13 trials), "Heart Failure" (10 trials), "Stage IV Lung Cancer AJCC v8" (8 trials), "Coronary Artery Disease" (6 trials) and "Recurrent Breast Carcinoma" (6 trials). Many other conditions were trialed in "Holy Cross Hospital" in a lesser frequency.

Most popular intervention types in "Holy Cross Hospital" are "Drug" (185 trials), "Other" (108 trials), "Biological" (71 trials), "Procedure" (44 trials) and "Device" (36 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (50 trials), "Quality-of-Life Assessment" (44 trials), "Paclitaxel" (35 trials), "Carboplatin" (29 trials) and "Questionnaire Administration" (26 trials). Other intervention names were less common.

The vast majority of trials in "Holy Cross Hospital" are 221 trials for "All" genders, 39 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Holy Cross Hospital". undefined are not yet recruiting, 66 are recruiting, 81 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 92 completed trials in Holy Cross Hospital, 6 suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in Holy Cross Hospital, 18 "Phase 1" clinical trials were conducted, 94 "Phase 2" clinical trials and 113 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 26 trials that are defined as “Not Applicable".

Holy Cross Hospital has several departments that took part in Clinical trials: "Michael and Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital" - 71 trials, "Holy Cross Orthopedic Institute" - 11 trials, "Cardiology Associates of Fort Lauderdale" - 6 trials, "Jim Moran Heart and Vascular Research Institute" - 5 trials, "Phil Smith Neuroscience Institute at Holy Cross Hospital" - 2 trials